Crestline Management, L.P.

CIK 0001536054 · FORT WORTH, TX · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗

Crestline Management, L.P. reported 3 positions worth $53.5M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: DNLI (91.9%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.

$53.5M

2026 Q2

Positions

Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.

100.0%

Est. Net Flow (Q)

—

2026 Q2

Positions Changes Mix History BacktestPRO

3 positions shown

#	Symbol	Company	Type	Value ↓	% Port.	Shares	1Y	YTD
▸ 1	DNLI	DENALI THERAPEUTICS INC	SH	$49.1M	91.90%	1,910,732	—	—
▸ 2	SANA	SANA BIOTECHNOLOGY INC	SH	$2.6M	4.93%	755,736	—	—
▸ 3	EGHT	8X8 INC NEW	SH	$1.7M	3.17%	990,850	—	—

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Crestline Management, L.P. hold as of Q2 2026?

Crestline Management, L.P. reported 3 positions worth $53.5M in its Q2 2026 13F filing. Largest positions: DNLI (91.9%), SANA (4.9%) and EGHT (3.2%).

What did Crestline Management, L.P. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Crestline Management, L.P. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.